Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 46,925 | 184,492 | 167,735 | 256,464 | 113,992 |
| Cost of Goods | 14,712 | 77,488 | 61,334 | 83,369 | 39,962 |
| Gross Profit | 32,213 | 107,004 | 106,401 | 173,095 | 74,030 |
| Operating Expenses | 63,173 | 44,357 | 45,338 | 45,237 | 44,229 |
| Operating Income | -30,248 | 63,135 | 61,397 | 128,227 | 30,763 |
| Interest Expense | 1,686 | 1,684 | 1,685 | 1,683 | 1,680 |
| Other Income | 8,218 | 6,523 | 4,380 | 2,830 | 3,776 |
| Pre-tax Income | -23,716 | 67,974 | 64,092 | 129,374 | 32,859 |
| Income Tax | 616 | 241 | 283 | 619 | 0 |
| Net Income Continuous | -24,332 | 67,733 | 63,809 | 128,755 | 32,859 |
| Net Income | $-24,332 | $67,733 | $63,809 | $128,755 | $32,859 |
| EPS Basic Total Ops | -0.19 | 0.54 | 0.50 | 1.02 | 0.26 |
| EPS Basic Continuous Ops | -0.19 | 0.53 | 0.50 | 1.02 | 0.26 |
| EPS Diluted Total Ops | -0.19 | 0.45 | 0.43 | 0.87 | 0.22 |
| EPS Diluted Continuous Ops | -0.19 | 0.44 | 0.42 | 0.86 | 0.22 |
| EBITDA(a) | $-32,091 | $62,372 | $61,416 | $129,911 | $32,310 |